Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement
You can also search for this author in PubMed Google Scholar
A long-awaited report on how US health officials should regulate research involving dangerous pathogens has been approved — sort of. On 27 January, a panel of experts joined a virtual meeting of the US National Science Advisory Board for Biosecurity (NSABB) expecting to vote on a set of recommendations developed by a pair of working groups. So many concerns were lodged, however, that the meeting ended with an agreement to modify the report — although without a firm plan for how to do so.
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 614, 206-207 (2023)
doi: https://doi.org/10.1038/d41586-023-00257-0
Correction 30 January 2023: An earlier version of this story stated that a study in which researchers inserted a gene from the Omicron variant of SARS-CoV-2 into an older strain of the virus was posted online without peer review. An early-access version of it has now been published in Nature.
Correction 31 January 2023: An earlier version of this story located Gigi Kwik Gronvall in Washington DC. She is at Johns Hopkins University in Baltimore, Maryland.
Imai, M. et al. Nature 486, 420–428 (2012).
Article PubMed Google Scholar
Herfst, S. et al. Science 336, 1534–1541 (2012).
Article PubMed Google Scholar
Chen, D.-Y. et al. Nature https://doi.org/10.1038/s41586-023-05697-2 (2023).
Article Google Scholar
Download references
Reprints and Permissions
Which COVID studies pose a biohazard? Lack of clarity hampers research
Risky ‘gain-of-function’ studies need stricter guidance, say US researchers
The shifting sands of ‘gain-of-function’ research
US government lifts ban on risky pathogen research
The sex-specific factor SOA controls dosage compensation in Anopheles mosquitos
Article
The brain cells linked to protection against dementia
News
The search for a connection between RSV and asthma
Outlook
Genetic variant powers up immune cells that remember SARS-CoV-2
Research Highlight
COVID lockdowns altered babies’ microbiomes
News
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes
Article
The UK’s rollback of climate policies will cost its citizens and the world
World View
AI tools as science policy advisers? The potential and the pitfalls
Comment
Governance: a Pugwash council for the digital age
Correspondence
The Center for Evolutionary & Organismal Biology invites applications from evolutionary scientists for All ranks.
Hangzhou, Zhejiang, China
Center for Evolutionary & Organismal Biology, Zhejiang University
10 fully-funded PhD positions in the field of animal conservation and cryobiology are offered in the new EU HORIZON-MSCA-Doctoral Network CryoStore.
Norway (NO)
CryoStore
The University of Wisconsin-Madison seeks a Director for the Wisconsin National Primate Research Center (WNPRC).
Madison, Wisconsin
University of Wisconsin-Madison Office of Vice Chancellor for Research
New Orleans, Louisiana
Tulane University School of Medicine
The Department of Human Genetics at the University of Michigan Medical School (Ann Arbor, Michigan) seeks to fill two tenure-track faculty position…
Ann Arbor, Michigan
University of Michigan – Human Genetics
Which COVID studies pose a biohazard? Lack of clarity hampers research
Risky ‘gain-of-function’ studies need stricter guidance, say US researchers
The shifting sands of ‘gain-of-function’ research
US government lifts ban on risky pathogen research
An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.
Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.
© 2023 Springer Nature Limited